LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE: […]
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market Read More »
On Wednesday, Novavax (NASDAQ: NVAX), the U.S.-based vaccine maker, said it would sell its manufacturing facility in the Czech Republic
Novavax to Sell Czech Manufacturing Unit to Novo Nordisk for $200 Million Read More »
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage Read More »
More than 200,000 prescriptions for copies of Novo Nordisk’s (NYSE: NVO) weight-loss drug Wegovy are getting filled by U.S. patients
Exclusive: Thousands Turn to Wegovy Copies Each Month as FDA Considers Shortage Status Read More »
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk’s (NYSE: NVO) highly in-demand drugs for diabetes
US Minority Veterans Face Unequal Access to Ozempic and Wegovy, Study Finds Read More »
LONDON – Novo Nordisk’s (NYSE: NVO) sales growth next year could be in the high teens in percentage terms, Chief
Novo Nordisk CFO Forecasts High-Teens Sales Growth for 2025 Read More »
COPENHAGEN – Novo Nordisk (NYSE: NVO) is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States
Novo Nordisk Lifts Curbs on Wegovy Prescriptions in the US, CEO Says Read More »
COPENHAGEN – On Wednesday, Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug, reassuring investors worried that
Novo Nordisk Stock Jumps as Q3 Wegovy Sales Top Estimates Read More »
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) chief financial officer Karsten Munk Knudsen said the company was aware of
Novo Nordisk is Aware of 10 Deaths From Compounded Weight-Loss Drug Copies Read More »
Copyright © 2025 abbonews.com
